Molecular Design of Anticancer Drug from Marine Fungi Derivatives

preprint OA: closed
View at publisher

Abstract

Heat shock protein 90 (HSP90) is known as one of the most potential target in cancer therapy. In this context, we have demonstrated that marine fungi derivatives can play as possible inhibitors for preventing the biological activity of HSP90 using a combination of molecular docking and fast pulling of ligand (FPL) simulations. In particular, the computational approaches were validated since compared with the respective experiments. Based on a benchmark on available inhibitors of HsP90, GOLD docking package using ChemPLP scoring function was found to be dominated over both Autodock Vina and Autodock4 in preliminary estimation the ligand binding affinity and binding pose with the Pearson correlation, R=-0.62. Moreover, FPL calculations were also indicated to be a suitable approach to refine docking simulations with a correlation coefficient with the respective experimental data of R=-0.81. Therefore, the binding affinity of marine fungi derivatives to Hsp90 was evaluated. Docking and FPL calculations suggested that five compounds including 23, 40, 46, 48, and 52 are as highly potential inhibitors for HSP90. The obtained results probably enhance the cancer therapy.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-05-19T01:45:01.086888+00:00